|
INO80 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.777530E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.557030E-04 |
| Normal-vs-Stage2 |
1.053860E-02 |
| Normal-vs-Stage3 |
2.938000E-03 |
| Normal-vs-Stage4 |
1.984790E-03 |
| Stage1-vs-Stage2 |
8.601800E-01 |
| Stage1-vs-Stage3 |
8.644400E-01 |
| Stage1-vs-Stage4 |
4.735600E-01 |
| Stage2-vs-Stage3 |
7.509600E-01 |
| Stage2-vs-Stage4 |
3.799200E-01 |
| Stage3-vs-Stage4 |
5.272400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.762000E-04 |
| Normal-vs-AfricanAmerican |
9.041700E-04 |
| Normal-vs-Asian |
4.395700E-03 |
| Caucasian-vs-AfricanAmerican |
8.901200E-01 |
| Caucasian-vs-Asian |
4.617000E-01 |
| AfricanAmerican-vs-Asian |
4.483400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78516000000073E-05 |
| Normal-vs-Female |
1.692840E-01 |
| Male-vs-Female |
9.121700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.257900E-03 |
| Normal-vs-Extreme_Weight |
8.07780000000591E-05 |
| Normal-vs-Obese |
4.057700E-03 |
| Normal-vs-Extreme_Obese |
1.096810E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.153800E-01 |
| Normal_Weight-vs-Obese |
5.611800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.236000E-01 |
| Extreme_Weight-vs-Obese |
2.816200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.718600E-01 |
| Obese-vs-Extreme_Obese |
2.938200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.941500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.259710E-02 |
| Normal-vs-Age(61-80Yrs) |
1.53072999999893E-05 |
| Normal-vs-Age(81-100Yrs) |
1.416640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.037200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.836200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.015030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.922500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.604010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.283400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.574400E-04 |
| Normal-VS-Type2 PRCC |
1.6214399999992E-05 |
| Normal-VS-KIRP CIMP |
2.549800E-02 |
| Normal-VS-Unclassified PRCC |
3.458000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.234240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.836000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.081980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.856200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.325740E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.544400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59900000018531E-07 |
| Normal-vs-N1 |
1.563980E-03 |
| Normal-vs-N2 |
2.168300E-02 |
| N0-vs-N1 |
3.856800E-01 |
| N0-vs-N2 |
9.835200E-01 |
| N1-vs-N2 |
7.362400E-01 |
|
|
